GlobalData Alternative: Focused Trial Change Detection With Public Pricing
GlobalData's pharma intelligence platform is a broad commercial dataset with disease analysis and forecasts: pricing is not published and access starts with a demo request. DataLookout does one part of that job: detecting when trials change, every day, automatically.
Who actually looks for a GlobalData alternative?
- A biotech selecting an intelligence platform reported a GlobalData quote of around $30,000 a year for a small licence, and called the enterprise options expensive and overkill for a company with a specific focus. (r/biotech thread, October 2024)
- A former user at a company of under 500 people put their spend at five figures for Evaluate and six figures for GlobalData at the same employer, and said they would not pay for any of them out of pocket. (r/biotech thread, November 2023)
- A BD professional listed GlobalData, Cortellis and DRG as the best tools for deal comps, search and evaluation, and market sizing. That is project work. The daily work, noticing that a competitor's trial changed, is what DataLookout does. (same thread)
If the job is a standing daily watch on a sponsor or a disease area, DataLookout does it for $49/month with a free tier to start and no contract. If the job is deal comps and market sizing, it is not the tool.
| Feature | GlobalData | DataLookout |
|---|---|---|
| Pricing | Not published; demo request | $0, or $49/month, public, self-serve |
| Contract | Not stated on the product page | Monthly or yearly, cancel anytime |
| Daily change detection | Not mentioned | Automated, each change marked Stopped, Notable or Minor |
| Change digest by email | Not mentioned | Built-in on every plan |
| Endpoint, site-count and enrollment changes | Not mentioned | Detected automatically, 13 tracked fields |
| Disease analysis and forecasts | Yes | No |
| Pipeline and marketed-drug sales forecasts | Yes | No |
| Deals, pricing and HTA, patent-expiry tracking | Yes | No |
| Setup | Demo request | 2 minutes |
| Free tier | None mentioned | Yes, free forever |
What does GlobalData offer?
GlobalData's pharma product page (checked August 22, 2026) lists pipeline and marketed drugs with sales forecasts, clinical trials, a regulatory-milestones and patent-expiry tracker, company profiles and M&A deals, drug pricing and HTA decisions, and disease analysis and forecasts across geographies.
- Clinical trials, investigators and sites alongside pipeline and marketed-drug data
- Disease analysis and forecasts by geography
- Deals, drug pricing, HTA and patent-expiry tracking
- Sold by demo request; no published price and no free tier mentioned
Where does DataLookout fit?
GlobalData tells you what the trial landscape looks like. DataLookout tells you what changed since yesterday in the trials you watch.
If a competitor's Phase 3 trial expands from 44 to 61 sites, if enrollment jumps 40%, if a primary endpoint gets rewritten, DataLookout catches it the next morning and tells you whether it is a stop, a notable change or a minor one.
GlobalData's product page does not mention change alerts (checked August 22, 2026). DataLookout is built for that one job: daily competitive awareness on the sponsors and disease areas you choose.
Can you use DataLookout alongside GlobalData?
If you already have GlobalData, DataLookout adds a daily change layer without replacing it: GlobalData for landscape work and forecasts, DataLookout for the morning email that says what moved. At $0 or $49/month it does not need a second procurement.
Frequently asked questions
Try DataLookout free
1 sponsor + 1 disease watchlist with daily change detection. Free forever, no credit card.
Get started freeDataLookout checks ClinicalTrials.gov every day and records what changed on each trial: status, enrollment, phase, primary endpoint, completion dates, sites, sponsor, and the stated reason a trial stopped. Add a sponsor or a disease to your watchlist, or save any search, and the changes arrive in a daily or weekly email digest.
Free, $0 forever: 1 sponsor + 1 disease watchlist, 1 saved search in your email digest, track up to 5 individual trials, daily change detection, Trials at Risk (top 2 trials), the weekly report (top 3 trials). No credit card.
Pro, $49/month or $490/year: 10 sponsor + 10 disease watchlists, 10 saved searches in your email digest, track up to 25 individual trials, full Trials at Risk list, Completions calendar, the full weekly report, landscape reports, CSV export.